Sirtex has been ordered to turn over information related to a possible acquisition to law firm Maurice Blackburn, which is leading a shareholder class action against the life sciences company.
A class action against Johnson & Johnson unit Ethicon over allegedly faulty pelvic mesh implants is once more vying for an expanded group definition ahead of settlement talks as the clock ticks down to judgment.
AFT Pharmaceuticals has accused rival Reckitt Benckiser of using the court as a “clearance house” to beat its competitors, the latest development in a long-running dispute over AFT’s Maxigesic ads.
Pharmaceutical giant Mylan has been ordered to hand over documents relating to its proposed launch of a generic version of its cholesterol drug Lipidil to rival Sun Pharma in advance of a hearing on Mylan’s request for an order blocking Sun from launching its own generic version of the drug.
An appeals court has dismissed a banned medical doctor’s challenge to the granting of three vexatious proceedings orders on constitutional grounds that the judge who made the orders was too old.
In a first for the NSW Supreme Court, Judge Peter Garling last week found that the plaintiff in a class action does not need to have a claim against all defendants, a case that could make life much easier for plaintiff lawyers, says barrister Daniel Meyerowitz-Katz of Second Floor Wentworth Chambers.clas
Generic pharmaceutical firm Sandoz has won a temporary stay of a $26.3 million judgment in a patent case as it awaits a decision by the Commissioner of Patents regarding a licence to make a cheaper version of the bestselling antidepressant Lexapro.
The Commonwealth Department of Public Prosecutions has told the Federal Court it will “very significantly” reduce the number of criminal charges laid against mobility equipment supplier Country Care Group as the landmark cartel case heads to trial in October.
A judge has rejected a motion by the NSW government and 15 local health districts to shut down a class action by the relatives of overseas patients who were forced to serve as guarantors and hit with hospital bills worth tens of thousands of dollars.
The trial in the ACCC’s case against hospital group Ramsay Health Care has doubled in length after the regulator made a late bid to enter as evidence a file note based on a sound recording of a meeting in which a Ramsay unit’s CEO allegedly made anti-competitive threats.